Biological systems are complex systems that can be understood in terms of design principles. Based on this premise, I have carried out my research in these areas:
Now I am focusing on an HIV project, aiming to construct a comprehensive mathematical model of host immune response to HIV exposure. I will use the model to study the dynamics and effectiveness of the host response and develop therapeutic strategies for HIV infection
Citation | Link |
---|---|
Reversible phosphorylation subserves robust circadian rhythms by creating a switch in inactivating the positive element. Cheng Z, Liu F, Zhang XP, Wang W. Biophys J. 97(11):2867-75. (2009) |
PubMed |
Cell fate decision mediated by p53 pulses. Zhang XP, Liu F, Cheng Z, Wang W. PNAS. 106:12245-50. (2009) |
PubMed |
Robustness analysis of cellular memory in an autoactivating positive feedback system. Cheng Z, Liu F, Zhang XP, Wang W. FEBS Lett. 582:3776-82. (2008) |
PubMed |
Linking fast and slow positive feedback loops creates an optimal bistable switch in cell signaling. Zhang XP, Cheng Z, Liu F, Wang W. Phys Rev E. 76, 031924. (2007) |
PubMed |
Ph.D Physics (Biophysics) (2008)
The University of North Carolina. Chapel Hill, NC
Department of Physics and Astronomy
Program in Cellular and Molecular Biophysics (T. Elston Lab, Dept. of Pharmacology)
Dissertation topic: “Dynamic regulation and information transfer in intracellular-signaling pathways”
M.S. Physics (2005)
The University of North Carolina. Chapel Hill, NC
Department of Physics and Astronomy (Y. Wu Lab)
Masters Topic: “NMR study of Anomalous spin relaxation in carbon nanotubes”
Licentiate Physical Sciences (1999)
University of Buenos Aires. Buenos Aires, Argentina
Check out more about me and my research at CellularCrossroads.org
I am interested in dynamical aspects of intracellular signaling events and the mechanisms that impart signal specificity.
My research goal is to understand the functional principles underlying biological networks. To this end, I use mathematical models, single-cell experiments, and multi-scale computational simulations to gain insight about how cells overcome the operational constraints they face when dealing with changing environmental and internal conditions. Many of the most significant advances in the life sciences arose from collaborations that cut across disciplines. My approach to scientific research is multidisciplinary and collaborative. I expect findings to enable novel therapeutic strategies based on the restoration of malfunctioning information pathways or induction of new patterns of information flow to control cellular functions impacted by disease.
14. Shinohara H*, Behar M*, Inoue K, Hiroshima M, Yasuda T, Nagashima T, Kimura S, Sanjo H, Maeda S, Yumoto N, Ki S, Akira S, Sako Y, Hoffmann A, Kurosaki T, Okada-Hatakeyama M (2014). Positive Feedback Within a Kinase Signaling Complex Functions as a Switch Mechanism for NF-κB Activation, Science, 344, pp.760-764. PMID: 24833394. (* equal contribution)
13. Behar, M., B.arken, D., Werner, S.L., Hoffmann, A (2013). The Dynamics of Signaling as a Pharmacological Target. Cell, 155, pp.448-461. PMID: 24120141.
The equilibrium, quasi-equilibrium, and out-of equilibrium parts of a signal can be manipulated through different perturbation strategies and, under some conditions, selectively suppressed (or enhanced)
12. Mukherjee SP, Behar M, Birnbaum HA, Hoffmann A, Wright PE, et al. (2013). Analysis of the RelA:CBP/p300 Interaction Reveals NF-κB-Driven Transcription. PLoS Biol 11(9): e1001647. doi:10.1371/journal.pbio.1001647. PMID: 24019758.
I’m interested in all things concerning T cells. I received my Ph.D. with studies of T cell cytotoxicity and activation. Currently I’m working on how different IkBs influence T cell proliferation and survival.
Citation | Link |
---|---|
Hydrolysis of tumor cell lipids after cytotoxic T lymphocyte (CTL)-mediated death. Bryce N. Alves, Jeff Leong, David Tamang, Viki Elliott, Mark Lowe, and Dorothy Hudig. Int Immunol. 2009 May;21(5):543-53. |
PubMed |
Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in CTLs and reevaluation of the negative effects of its gene ablation on cytotoxicity. Bryce N. Alves, Jeff Leong, David Tamang, Viki Elliott, Jillian Edelnant, Doug Redelman, Cherrie A. Singer, Andy R Kuhn, Rita Miller, Mark E Lowe, and Dorothy Hudig. J Leukoc Biol. 2009 Sep;86(3):701-12. |
PubMed |
Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs). Bryce N. Alves, Kristen Marshall, David L.Tamang, Jeff Leong, Doug Redelman, Viki Elliott, Mark E. Lowe, and Dorothy Hudig. Cell Biochem Funct. 2009 Jul;27(5):296-308 |
PubMed |